Roivant may be further ahead with their pivotal BREATHE trial
May 13th they had an interim and disclosed 56 patients enrolled at that time ...more sites than HGEN including sites at Mt Sinai . They will enroll up to 270 patents vs 238 for HGEN ...but started earlier and may be enrolling faster .